Cardiovascular Portfolio
Cardiovascular disease remains one of the most important areas of long-term pharmaceutical care, requiring dependable access to quality medicines across prevention, acute management and chronic treatment. Product quality, manufacturer reliability, regulatory compliance, appropriate storage and continuity of supply are essential when supporting hospitals, clinics, pharmacies, distributors and other healthcare providers.
Our Cardiovascular Portfolio is designed to give our partners access to a flexible range of pharmaceutical products used across major cardiovascular treatment areas. Depending on product availability, registration status and applicable regulatory requirements, we can explore medicines for hypertension, dyslipidaemia, heart failure, thrombosis prevention, angina, arrhythmias and other cardiovascular conditions.
We understand that cardiovascular care often involves long-term therapy and continuous patient access. For this reason, our sourcing approach focuses on reputable manufacturers, dependable supply planning, regulatory suitability, competitive commercial positioning and coordinated logistics. Where a required cardiovascular medicine is not already within our portfolio, we can explore suitable sourcing opportunities through our international manufacturer network.
Key Features
- Access to reputable international manufacturers producing cardiovascular pharmaceutical products
- Flexible sourcing across major cardiovascular therapeutic classes
- Access to different strengths, dosage forms, pack sizes and commercial options depending on market requirements
- Manufacturer and product evaluation based on quality, documentation, regulatory suitability, availability and commercial value
- Coordination of technical documentation, product registration and applicable market-access requirements in Kenya
- International procurement, shipment planning, importation, customs coordination and local delivery support
- Ability to explore specific cardiovascular molecules outside our existing portfolio through our global manufacturer network
- A long-term partnership approach focused on continuity of supply and sustainable portfolio development
Specifications & Portfolio Scope
Therapeutic Scope - Our sourcing capabilities may include medicines used in hypertension management, lipid control, heart failure, anticoagulation and antiplatelet therapy, angina, arrhythmias and other cardiovascular treatment areas.
Product Categories - Depending on manufacturer capability and market requirements, products may include antihypertensives, statins and other lipid-lowering agents, antiplatelet medicines, anticoagulants, beta blockers, calcium-channel blockers, ACE inhibitors, angiotensin receptor blockers, diuretics, antianginal products and selected heart-failure therapies.
Dosage Forms - Products may be available as tablets, capsules, coated tablets, oral solutions, injectable preparations and other appropriate pharmaceutical presentations.
Supply Options - We can assess requirements ranging from individual product enquiries and distributor portfolio expansion to hospital, institutional and larger commercial supply needs.
Regulatory Status - Registration requirements vary by individual product. Products intended for commercial supply are handled according to applicable Kenyan pharmaceutical regulations, with the necessary documentation and market-access procedures coordinated where required.
Storage & Logistics - Products are handled according to manufacturer-defined storage and transportation requirements, with appropriate logistics arrangements coordinated throughout the supply process.

Specifications & Portfolio Scope
More Than a Supplier. Your Cardiovascular Sourcing Partner.

More Than a Supplier. Your Cardiovascular Sourcing Partner.
Our objective is not simply to provide cardiovascular medicines. We aim to become a dependable sourcing and market partner capable of connecting healthcare providers and distributors with the right manufacturers, appropriate products, suitable regulatory pathways and sustainable supply solutions.
Whether you are expanding a cardiovascular product portfolio, responding to hospital demand, sourcing a specific molecule or seeking reliable international manufacturing partners, IHIT Kenya provides a single point of coordination from initial enquiry through to commercial market supply.
Frequently asked questions
We can explore a broad range of medicines used across cardiovascular care, including antihypertensives, lipid-lowering medicines, antiplatelet and anticoagulant products, heart-failure therapies, antianginal medicines, antiarrhythmics and other related products.
Registration status depends on the individual product. Where registration or other market-access procedures are required, we coordinate with manufacturers and relevant partners to support the necessary documentation and regulatory processes.
Yes. Through our international network, we can approach suitable manufacturers and assess products according to the required active ingredient, strength, dosage form, quality specifications, registration requirements, availability and commercial considerations.
Yes. We can assess multiple product requirements and help identify suitable sourcing options across different cardiovascular therapeutic classes, enabling distributors to build a more comprehensive and commercially relevant portfolio.
Yes. We can support manufacturers with market assessment, regulatory coordination, registration support, importation, distribution arrangements and commercial market development in Kenya.






